Larval therapy in wound management: A review

International Journal of Clinical Practice

Volumn 61, Issue 3, 2007, Pages 488-493

  Parnes A ^a   Lagan, Katie M ^b  

^a North and West Belfast HSST   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; METICILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERICIDAL ACTIVITY; BURN; CLINICAL EFFECTIVENESS; DEBRIDEMENT; DECUBITUS; DISINFECTION; FASCIITIS; FOOT AMPUTATION; FOOT ULCER; HOSPITAL INFECTION; HUMAN; LEG ULCER; MAGGOT THERAPY; MEDICAL LITERATURE; MEDICAL RESEARCH; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; OSTEOMYELITIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; ULCER; WOUND; WOUND DRESSING; WOUND HEALING; WOUND INFECTION;

ANIMALS; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; DEBRIDEMENT; HEALTH CARE COSTS; HUMANS; LARVA; TREATMENT OUTCOME; WOUND HEALING;

EID: 33847082890     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01238.x     Document Type: Review

References (74)

1. Beasley WD, Hirst G. Making a meal of MRSA - the role of biosurgery in hospital-acquired infection. J Hosp Infect 2004; 56: 6-9.
2. Romanelli M, Mastronicola D. The role of wound-bed preparation in managing chronic pressure ulcers. J Wound Care 2002; 11: 305-10.
3. Hoffmann J, Hetru C. Insect defensins: inducible antibacterial peptides. Immunol Today 1992; 13: 411-5.
4. Grossman J. Flies as medical allies. The world & I 1994; 9: 187-93.
5. Evans H. A treatment of last resort. Nurs Times 1997; 93: 62-5.
6. Sherman RA, Wyle F, Vulpe M. Maggot debridement therapy for treating pressure ulcers in spinal cord injury patients. J Spinal Cord Med 1995; 18: 71-4.
7. Goodman N. Sacred cows to the abattoir! Clinical Governance. BMJ 1998; 317: 1725-7.
8. Courtenay M. The use of larval therapy in wound management in the UK. J Wound Care 1999; 8: 177-9.
9. Mumcuoglu K, Ingber A, Gilead L et al. Maggot therapy for the treatment of intractable wounds. Int J Dermatol 1999; 38: 623-7.
10. Scavée V, Polis FR-X, Schoevaerdts J-Cl. Maggot therapy: many hands make light work. Acta Clin Belg 2003; 103: 405-7.
11. Sealby N. The use of maggot therapy in the treatment of a malignant foot wound. Br J Community Nurs 2004; 9: S16-9.
12. Stoddard SR, Sherman RM, Mason BE et al. Maggot debridement therapy - an alternative treatment for non-healing ulcers. J Am Podiatr Med Assoc 1995; 85: 218-21.
13. Knowles A, Findlow A, Jackson N. Management of a diabetic foot ulcer using larval therapy. Nurs Stand 2001; 16: 73-6.
14. Semple L. Use of larval therapy to treat a diabetic patient's pressure ulcer. Br J Nurs 2003; 12: S6-13.
15. Richardson M. The benefits of larval therapy in wound care. Nurs Stand 2004; 19: 70-6.
16. Kitching M. Patients' perceptions and experiences of larval therapy. J Wound Care 2004; 13: 25-9.
17. Lau H, Lee F. Maggots in surgery. Ann Coll Surg 1999; 4: 50-3.
18. Green T. Larval therapy in the community - challenge or opportunity? Nurse to Nurse 2004; 4: 51-2.
19. Trudigan J. Evaluating the benefits of larval therapy. Nurs Stand 2002; 16: 65-73.
20. Wayman J, Walker A, Sowinski A et al. Larval debridement therapy: a cost-effective alternative to hydrogel in necrotic venous ulcers: a randomised trial. Br J Surg 2000; 87: 507.
21. MacDougall KM, Rodgers FR. A case study using larval therapy in the community setting. Br J Nurs 2004; 13: 255-60.
22. Sherman RA, Sherman J, Gilead L et al. Maggot debridement therapy in outpatients. Arch Phys Med Rehabil 2001; 82: 1226-9.
23. Kapil A. The challenge of antibiotic resistance: need to contemplate. Indian J Med Res 2005; 121: 83-91.
24. Wise R, Hart T, Cars O et al. Antimicrobial resistance is a major threat to public health. BMJ 1998; 317: 609-10.
25. Liu C, Chambers HF. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother 2003; 47: 3040-5.
26. Chopra I. Antibiotic resistance in Stahylococcus aureus: concerns, causes and cures. Exper Rev Anti Infect Ther 2003; 1: 45-55.
27. Brocklesby S. MRSA, macrophages and maggots. The Diabetic Foot 2002; 5: 16-24.
28. Thomas S, Andrews A, Hay NP et al. The anti-microbial activity of maggot secretions: results of a preliminary study. J Tissue Viability 1999; 9: 127-32.
29. Steenvoorde P, Jukema GN. The antimicrobial activity of maggots: in vivo results. J Tissue Viability 2004; 14: 97-101.
30. Thomas S, Jones M. Maggots can benefit patients with MRSA. J Pract Nurs 2000; 20: 101-4.
31. Bexfield A, Nigam Y, Thomas S et al. Detection and partial characterisation of two antibacterial factors from the excretions/secretions of the medicinal maggot Lucilia sericata and their activity against methicillin-resistant Staphylococcus aureus (MRSA). Microbes Infect 2004; 6: 1297-304.
32. Sherman RA. Maggot therapy - the last five years. Bull Eur Tissue Repair Soc 2000; 7: 97-8.
33. Evans H. Larvae therapy and venous leg ulcers: reducing the "yuk factor". J Wound Care 2002; 11: 407-8.
34. Grassberger M, Fleischmann W. The biobag - a new device for the application of medicinal maggots. Dermatology 2002; 204: 306.
35. Fear M, Warrell R, Allum L. Introducing the use of sterile maggots into a primary care trust: overcoming barriers. Br J Community Nurs 2003; 8: S24-30.
36. Rayman A, Stansfield G, Woollard T et al. Use of larvae in the treatment of the diabetic necrotic foot. The Diabetic Foot 1998; 1: 7-13.
37. Jones M, Thomas S. Larval therapy. Nurs Stand 2000; 14: 47-51.
38. Wolff H, Hansson C. Larval therapy - an effective method of ulcer debridement. Clin Exp Dermatol 2003; 28: 134-7.
39. Johnson S. Larval therapy in the treatment of wounds: case history. Br J Community Nurs 1999; 4: 293-5.
40. Thomas S, Jones M. The use of sterile maggots in wound management. Wound Care Soc Educ Leaflet 1999; 6.
41. Nuesch R, Rahm G, Rudin W et al. Clustering of bloodstream infections during maggot debridement therapy using contaminated larvae of Protophormia terraenovae. Infection 2002; 5: 306-9.
42. Thomas S, Jones M, Shutler S et al. All you need to know about maggots. Nurs Times 1996; 92: 63-76.
43. Wollina U, Karte K, Herold C et al. Biosurgery in wound healing - the renaissance of maggot therapy. J Eur Acad Dermatol Venereol 2000; 14: 285-9.
44. Steed DL, Donohue D, Webster MW et al. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. J Am Coll Surg 1996; 183: 61-4.
45. Smith J. Debridement of diabetic foot ulcers. Cochrane Database Syst Rev 2002; 4: CD003556.
46. Armstrong DG, Lavery LA, Vazquez JR et al. How and why to surgically debride neuropathic diabetic foot wounds. J Am Podiatr Med Assoc 2002; 92: 402-4.
47. Thomas S, Jones M, Shutler S et al. Using larvae in modern wound management. J Wound Care 1996; 5: 60-9.
48. Gelbert M. Time's great healers. Nurs Times 1998; 94: 65-9.
49. Ballard K, Baxter H. Developments in wound care for difficult to manage wounds. Br J Nurs 2000; 9: 405-12.
50. Casu RE, Pearson RD, Jarmey JM et al. Excretory/secretory chymotrypsin from Lucilia cuprina: purification, enzymatic specificity and amino acid sequence deduced from mRNA. Insect Mol Biol 1994; 3: 201-11.
51. Vistnes LM, Lee R, Ksander GA. Proteolytic activity of blowfly larvae secretions in experimental burns. Surgery 1981; 90: 835-41.
52. Lerch K, Linde HJ, Lehn N et al. Bacteria ingestion by blowfly larvae: an in vitro study. Dermatology 2003; 207: 362-6.
53. Mumcuoglu K, Miller J, Mumcuoglu M et al. Destruction of bacteria in the digestive tract of the maggot of Lucilia sericata (Diptera: Calliphoridae). J Med Entomol 2001; 38: 161-6.
54. Armstrong DG, Mossel J, Short B et al. Maggot debridement therapy: a primer. J Am Podiatr Med Assoc 2002; 92: 398-401.
55. Fleischmann W, Grassberger M, Sherman R. Maggot Therapy: A Handbook of Maggot-assisted Wound Healing. New York: Thieme, 2004.
56. Robinson W. Stimulation of healing in non-healing wounds by allantoin occurring in maggot secretions and of wide biological distribution. J Bone Joint Surg 1935; 17: 267-71.
57. Simmons SW. A bactericidal principle in excretions of surgical maggots which destroys important etiological agents of pyogenic infections. J Bacteriol 1935; 30: 253-67.
58. Livingston SK. The therapeutic active principle of maggots. J Bone Joint Surg 1936; 18: 751-6.
59. Robinson W. Ammonium bicarbonate secreted by surgical maggots stimulates healing in purulent wounds. Am J Surg 1940; 47: 111-5.
60. Sherman RA. Maggot debridement in modern medicine. Infect Med 1998; 15: 651-6.
61. Erdmann GR, Bromel M, Gassner G et al. Antibacterial activity demonstrated by culture filtrates of Proteus mirabilis isolated from larvae of the screwworm (Cochliomyia hominivorax) (Diptera: Calliphoridae). J Med Entomol 1984; 23: 208-11.
62. Chambers L, Woodrow S, Brown AP et al. Cutaneous biology: degradation of extracellular matrix components by defined proteinases from the greenbottle larva Lucilia sericata used for the clinical debridement of non-healing wounds. Br J Dermatol 2003; 148: 14-23.
63. Sherman RA. Maggot therapy for treating diabetic foot ulcers unresponsive to conventional therapy. Diabetes Care 2003; 26: 446-51.
64. Sherman RA. Maggot versus conservative debridement therapy for the treatment of pressure ulcers. Wound Repair Regen 2002; 10: 208-14.
65. Boon H, Freeman L, Unsworth J. Larvae help debridement. Nurs Times 1996; 92: 76-80.
66. Husain ZS, Fallat LM. Maggot therapy for wound debridement in a traumatic foot-degloving injury: a case report. J Foot Ankle Surg 2003; 42: 371-6.
67. Wollina U, Liebold K, Schmidt WD et al. Biosurgery supports granulation and debridement in chronic wounds - clinical data and remittance spectroscopy. Int J Dermatol 2002; 41: 635-9.
68. Horn KL, Cobb AH Jr, Gates GA. Maggot therapy for subacute mastoiditis. Arch Otolaryngol Head Neck Surg 1976; 102: 377-9.
69. Preuss SF, Stenzel MJ, Esriti A. The successful use of maggots in necrotising fasciitis of the neck - a case report. Head Neck 2004; 26: 747-50.
70. Bengmark S, Rydberg B, Zederfedlt B. Cytotoxic action of quaternary ammonium compounds with special reference to wound healing. Bull Soc Int Chir 1968; 27: 56-63.
71. Pelle MT, Miller OF. Debridement of necrotic eschar with 40% urea paste speeds healing of residual limbs and avoids further surgery. Arch Dermatol 2001; 137: 1288-90.
72. Rayner K. Larval therapy in wound debridement. Prof Nurse 1999; 14: 329-33.
73. Prete PE. Growth effects of Phaenicia sericata larval extracts on fibroblasts: mechanism for wound healing by maggot therapy. Life Sci 1997; 60: 505-10.
74. Horobin AJ, Shakesheff KM, Woodrow S et al. Cutaneous biology: maggots and wound healing: an investigation of the effects of secretions from Lucillia sericata larvae upon interactions between human dermal fibroblasts and extracellular matrix components. Br J Dermatol 2003; 148: 923-33.